Table 4.
Characteristics | Overall Survival | Cancer-Specific Survival | ||
---|---|---|---|---|
Hazard Ratio (95% CI) | P value | Hazard Ratio (95% CI) | P value | |
Age, y | ||||
≤65 | Reference | Reference | ||
>65 | - | 0.657 | 0.402 | |
Gender | ||||
Male | Reference | Reference | ||
Female | 2.25 (1.14–4.44) | 0.020 | 0.284 | |
BMI, kg/m2 | ||||
<25 | Reference | Reference | ||
≥25 | - | 0.457 | 0.497 | |
Hypertension | ||||
No | Reference | Reference | ||
Yes | - | 0.484 | 2.95 (1.33–6.54) | 0.008 |
Diabetes | ||||
No | Reference | Reference | ||
Yes | - | 0.561 | - | 0.789 |
Cardiovascular Diseases | ||||
No | Reference | Reference | ||
Yes | - | 0.577 | - | 0.633 |
Smoking | ||||
No | Reference | Reference | ||
Yes | - | 0.881 | - | 0.847 |
Surgery Type | ||||
Partial nephrectomy | Reference | Reference | ||
Radical nephrectomy | - | 0.183 | 4.65 (1.51–14.28) | 0.007 |
Laterality | ||||
Left | Reference | Reference | ||
Right | - | 0.889 | - | 0.828 |
AJCC stage | ||||
I | Reference | Reference | ||
II | - | 0.290 | 1.13 (0.11–6.88) | 0.583 |
III | - | 0.203 | 2.10 (0.68–6.46) | 0.196 |
IV | - | 0.077 | 11.53 (4.62–28.75) | <0.001 |
T-stage | ||||
T1 | Reference | Reference | ||
T2 | - | 0.794 | - | 0.033 |
T3 | - | 0.297 | - | 0.491 |
T4 | - | 0.162 | - | 0.310 |
N-stage | ||||
N0 | Reference | Reference | ||
N1 | - | 0.056 | - | 0.254 |
M-stage | ||||
M0 | Reference | Reference | ||
M1 | 8.39 (3.87–18.19) | <0.001 | - | 0.338 |
Fuhrman Grade | ||||
I | Reference | Reference | ||
II | - | 0.891 | - | 0.878 |
III | - | 0.936 | - | 0.870 |
IV | - | 0.029 | - | 0.189 |
ALB | ||||
Reference | Reference | |||
0.155 | - | 0.125 | ||
NLR | ||||
Reference | Reference | |||
0.709 | - | 0.359 | ||
PLR | ||||
Reference | Reference | |||
0.233 | - | 0.874 | ||
SIRI | ||||
Grade 1 | Reference | Reference | ||
Grade 2 | 1.91 (0.87–4.21) | 0.109 | 1.27 (0.78–5.04) | 0.513 |
Grade 3 | 4.93 (2.21–11.00) | <0.001 | 6.29 (2.28–17.39) | <0.001 |
Abbreviations: OS, overall survival; CSS, cancer-specific survival; CI, confidence interval; BMI, body mass index; AJCC, American Joint Committee on Cancer; SIRI, systemic inflammation response index.